Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) ((PATH-SIC))
Breast Cancer, Gastrointestinal Cancer, Gynecologic Cancer
About this trial
This is an interventional other trial for Breast Cancer focused on measuring Breast Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Thoracic Cancer, Genitourinary Cancer, Serious Illness Communication
Eligibility Criteria
Inclusion Criteria: Patients who are aged 18 years or older, reach one of the poor prognosis nodes identified and have an upcoming appointment at one of the following Dana Farber Cancer Institute oncology clinics (including Longwood and Chestnut Hill locations) Breast Oncology Clinic Gastrointestinal Oncology Clinic Genitourinary Oncology Clinic Gynecologic Oncology Clinic Thoracic Oncology Clinic Exclusion Criteria: Patients with an SIC documented in the Advance Care Planning module of the electronic health record in the 6 months prior to reaching a poor prognosis node Patients who have previously been randomized in this trial (e.g., the patient is encountering a poor-prognosis node for the second time during the trial period)
Sites / Locations
- Dana Farber Cancer Institute
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
No Intervention
Experimental
Experimental
Both patient and clinician receive a nudge
Neither the patient nor clinician receive a nudge
Patient receives a nudge but not the clinician
Clinician receives a nudge but not the patient
Patient nudge consists of a letter and SHARE questionnaire Clinician "nudge" email encouraging discussion to initiate discussion on SIC
Standard Care
-Patient nudge consists of a letter and SHARE questionnaire
-Clinician "nudge" email encouraging discussion to initiate discussion on SIC